SCHEMBL24360911

SCHEMBL24360911

CC(C)(C)c1ccc(OC(=O)C(F)(F)C(F)(F)C(F)(F)C(=O)O)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.50
▸ TDP1 Q9NUW8 1/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ VCAM1 P19320 1/20 0.49
▸ RAB9A P51151 3/20 0.46
▸ NPSR1 Q6W5P4 2/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ NPC1 O15118 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ ELANE P08246 5/20 0.42
▸ ALDH1A1 P00352 1/20 0.40
▸ THRB P10828 1/20 0.40
▸ TRPV1 Q8NER1 1/20 0.40
▸ PRSS1 P07477 1/20 0.40
▸ ACR P10323 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24360921 0.90 MAPT (0.53) MAPTTDP1L3MBTL1RAB9ANPSR1
SCHEMBL24360897 0.85 SMN1; SMN2 (0.44) MAPTTDP1L3MBTL1VCAM1RAB9A
SCHEMBL24361172 0.82 VCAM1 (0.40) VCAM1KMT2AELANETHRBATM
SCHEMBL19432834 0.82 ELANE (0.42) MAPTTDP1L3MBTL1VCAM1ELANE
SCHEMBL24360875 0.81 VCAM1 (0.39) VCAM1ELANETHRBTRPV1RXRA
SCHEMBL6851503 0.80 MAPT (0.54) MAPTTDP1L3MBTL1RAB9ANPSR1
SCHEMBL16904842 0.76 ELANE (0.70) MAPTTDP1L3MBTL1RAB9ANPSR1
SCHEMBL24361455 0.76 SMN1; SMN2 (0.47) MAPTTDP1L3MBTL1RAB9ANPSR1
SCHEMBL24361171 0.74 CES2 (0.44) MAPTVCAM1ALDH1A1THRBKDM4E
SCHEMBL24361186 0.74 VCAM1 (0.61) TDP1VCAM1NPSR1ALDH1A1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220127225-A1 ONIUM SALT, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2022-04-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220127225-A1 ONIUM SALT, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS CACNA1F, SLC6A5, IDUA MAPT 2279/4885TDP1 3589/4885L3MBTL1 3555/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback